207 related articles for article (PubMed ID: 11115781)
21. Predominately glucocorticoid agonist actions of RU-486 in young specific-pathogen-free Zucker rats.
Havel PJ; Busch BL; Curry DL; Johnson PR; Dallman MF; Stern JS
Am J Physiol; 1996 Sep; 271(3 Pt 2):R710-7. PubMed ID: 8853395
[TBL] [Abstract][Full Text] [Related]
22. Thiazolidinediones influence plasma steroids of male obese Zucker rats.
Fürnsinn C; Nowotny P; Brunmair B; Gras F; Roden M; Waldhäusl W; Vierhapper H
Endocrinology; 2002 Jan; 143(1):327. PubMed ID: 11751625
[TBL] [Abstract][Full Text] [Related]
23. A novel genetically-obese rat model with elevated 11 beta-hydroxysteroid dehydrogenase type 1 activity in subcutaneous adipose tissue.
Prasad SS; Prashanth A; Kumar CP; Reddy SJ; Giridharan NV; Vajreswari A
Lipids Health Dis; 2010 Nov; 9():132. PubMed ID: 21083914
[TBL] [Abstract][Full Text] [Related]
24. Effect of adrenalectomy and corticosterone replacement on meal patterns of Zucker rats.
Freedman MR; Castonguay TW; Stern JS
Am J Physiol; 1985 Nov; 249(5 Pt 2):R584-94. PubMed ID: 4061679
[TBL] [Abstract][Full Text] [Related]
25. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II impairs glucose utilization in obese Zucker rats by increasing HPA activity via an adrenal-dependent mechanism.
Müller-Fielitz H; Raasch W
Horm Metab Res; 2013 Feb; 45(2):173-80. PubMed ID: 23104420
[TBL] [Abstract][Full Text] [Related]
27. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
28. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
[TBL] [Abstract][Full Text] [Related]
29. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
[TBL] [Abstract][Full Text] [Related]
30. Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats.
Umrani DN; Banday AA; Hussain T; Lokhandwala MF
Hypertension; 2002 Dec; 40(6):880-5. PubMed ID: 12468573
[TBL] [Abstract][Full Text] [Related]
31. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
32. Effect of adrenalectomy and high-fat diet on the fatty Zucker rat.
Bray GA; Stern JS; Castonguay TW
Am J Physiol; 1992 Jan; 262(1 Pt 1):E32-9. PubMed ID: 1733248
[TBL] [Abstract][Full Text] [Related]
33. Effect of adrenalectomy on the development of a pancreatic islet lesion in fa/fa rats.
Kibenge MT; Chan CB
Diabetologia; 1996 Feb; 39(2):190-8. PubMed ID: 8635671
[TBL] [Abstract][Full Text] [Related]
34. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
Stimson RH; Walker BR
Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
[TBL] [Abstract][Full Text] [Related]
35. Obese Zucker (fa/fa) rats exhibit normal target sensitivity to corticosterone and increased drive to adrenocorticotropin during the diurnal trough.
Walker CD; Scribner KA; Stern JS; Dallman MF
Endocrinology; 1992 Dec; 131(6):2629-37. PubMed ID: 1332842
[TBL] [Abstract][Full Text] [Related]
36. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
[TBL] [Abstract][Full Text] [Related]
37. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase in adipose tissue.
Seckl JR; Morton NM; Chapman KE; Walker BR
Recent Prog Horm Res; 2004; 59():359-93. PubMed ID: 14749510
[TBL] [Abstract][Full Text] [Related]
38. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
Kramer D; Shapiro R; Adler A; Bush E; Rondinone CM
Metabolism; 2001 Nov; 50(11):1294-300. PubMed ID: 11699047
[TBL] [Abstract][Full Text] [Related]
39. A switch in dehydrogenase to reductase activity of 11 beta-hydroxysteroid dehydrogenase type 1 upon differentiation of human omental adipose stromal cells.
Bujalska IJ; Walker EA; Hewison M; Stewart PM
J Clin Endocrinol Metab; 2002 Mar; 87(3):1205-10. PubMed ID: 11889189
[TBL] [Abstract][Full Text] [Related]
40. Insulin-sensitizing action of rosiglitazone is enhanced by preventing hyperphagia.
Pickavance LC; Buckingham RE; Wilding JP
Diabetes Obes Metab; 2001 Jun; 3(3):171-80. PubMed ID: 11412281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
